Zhang, S. et al. J Am Coll Cardiol Basic Trans Science. 2017;2(4):386-97. HIGHLIGHTS New therapies are needed to enhance myocardial salvage after myocardial ischemia and reperfusion. Human and murine hearts express CD47 and calreticulin that increased after ischemia and reperfusion. Phagocytic efficiency of dying cardiac myocytes was enhanced after antibody-mediated blockade of either myocyte CD47 or macrophage CD47-ligand, SIRPa. After ischemia and reperfusion, enhancement of dead myocyte clearance by macrophages, after CD47 blockade, improved inflammation resolution, reduced infarct size, and preserved cardiac systolic function.
SUMMARY
Our data suggest that, after a myocardial infarction, integrin-associated protein CD47 on cardiac myocytes is elevated. In culture, increased CD47 on the surface of dying cardiomyocytes impairs phagocytic removal by immune cell macrophages. After myocardial ischemia and reperfusion, acute CD47 inhibition with blocking antibodies enhanced dead myocyte clearance by cardiac phagocytes and also improved the resolution of cardiac inflammation, reduced infarct size, and preserved cardiac contractile function. Early targeting of CD47 in the myocardium after reperfusion may be a new strategy to enhance wound repair in the ischemic A lthough clinical management of acute myocardial infarction (AMI) has significantly reduced morbidity and mortality, the consequence of these advances include an emerging incidence of post-MI heart failure (1) . In turn, new approaches that enhance cardiac wound healing and are complementary to the current standards of care have the potential to improve on left ventricular (LV) systolic function (2) .
A critical determinant of heart failure susceptibility after AMI is infarct size (3) . Infarct size and loss of nonregenerative cardiomyocytes (CMs) by acute necrosis directly correlates with ventricular dysfunction and heart failure (4) . Infarct necrosis can also expand during reperfusion injury or after maladaptive inflammation, leading to accelerated and adverse ventricular remodeling (5, 6) .
During wound healing, clearance of dying cells must occur efficiently to prevent secondary necrosis and prolonged inflammation. Efficient phagocytic clearance of apoptotic cells by macrophages (Mfs) via efferocytosis, actively programs cellular inflammationresolution and tissue repair signaling pathways (7) . This clearing is particularly important in the heart, where inefficient removal of necrotic CMs may lead to collateral myocyte loss and infarct expansion (5, 8) . In a previous study, we experimentally linked the efficiency of phagocytic clearance to infarct size expansion and discovered that Mfs defective for efferocytosis led to deteriorated cardiac function after MI (9) . These studies begged additional questions, including the natural efficiency of CM clearance by phagocytic cells and whether strategies that target phagocytic enhancement might enhance heart healing. In this study, we focused on CM-intrinsic factors, namely CD47, that regulate phagocytic interactions with Mfs (10).
Dying cell engulfment requires cell surface presentation of so-called "eat-me" signals, such as phosphatidylserine and calreticulin, which must occur in tandem with downregulation of antiphagocytic Although CD47 expression has been profiled in neonatal CMs (14), much less is known about its expression and function in adult CMs. CD47 deficiency is associated with enhanced cardiac performance after administration of vasoactive agents (15) . In skeletal muscle, CD47 can regulate PGC-1adependent mitochondrial biogenesis through recognition of its thrombospondin ligand (16) . CD47 has also been linked to signaling in smooth muscle cells (17) . S e m i q u a n t i t a t i v e a n d q u a n t i t a t i v e r e v e r s e t r a n s c r i p t a s e p o l y m e r a s e c h a i n r e a c t i o n . Hearts were snap-frozen for RNA. Total RNA was extracted using the RNeasy kit (Qiagen, Hilden, Germany).
cDNA was synthesized from 4 mg of total RNA using oligo (dT) and Superscript II (Invitrogen). cDNA was subjected to quantitative reverse transcriptase polymerase chain reaction amplification using a SYBR Green PCR Master Mix (Applied Biosystems, Foster City, California). ADENOVIRUS ADMINISTRATION. CM specific-CD47 expression was induced as previously described (22) . Adeno-associated virus1-cTNTp-GFP-2A-mCD47-WPRE and adeno-associated virus1-cTNTp-GFP were from Vector Biolabs (Malvern, Pennsylvania). We administered 1 Â 10 12 adeno-associated virus into 6-week-old B6 mice and hearts were harvested for immunohistochemical staining to check for increased protein. Mfs, thioglycolate-elicited Mfs were prepared as described previously (23) . The isolation of cardiomyocytes and cardiac fibroblasts from adult hearts was performed as previously described (24) . In brief, 6-to 8-week-old B6 mice were injected intraperitoneally with 0.5 ml heparin solution before being anesthetized with tribromoethanol. The excised heart was immediately mounted to a modified Langendorff apparatus and perfused with perfusion buffer, digestion buffer, and stopping buffer in sequential order.
After enzyme dissociation, CMs were enriched through a gradient of calcium reintroduction buffer, and were plated accordingly for downstream experimentation. however, our understanding of CM-specific expression in humans is limited. We, therefore, first used immunohistochemistry of human hearts after autopsy to test for CM-specific CD47. As shown in Figure  1A , human (Supplemental Table  1 ,
Supplemental Figures 1 and 2) myocardial CD47
expression was found to colocalize to CMs; reduced colocalization was identified on other human cardiac cells, such as endothelial cells (Supplemental 
EX VIVO UPTAKE OF CM APOPTOTIC BODIES BY
MfS IS REGULATED BY THE CD47-SIRPa AXIS. We previously reported that phagocytosis is a significant early regulator of cardiac repair after an MI (9) , and furthermore that CMs are engulfed by Mfs at a lower efficiency than other cell types that turnover after an MI (18) . In that the Henson (10) and Weissman groups (11) have shown the potential of blocking CD47 to enhance phagocytosis, we reasoned that increased CD47 might render CMs particularly sensitive to CD47-phagocytic regulation. To test the potential of CD47 blockade for rescuing basal CM phagocytosis inefficiency, we added anti-CD47 blocking antibodies to cocultures of primary adult differentiated murine CMs and Mfs. Figure 2A shows that CD47 blockade significantly heightened CM efferocytosis, over and above isotype control, and specifically for apoptotic CMs (Figure 2B, Supplemental Figure 6 ). Efferocytosis enhancements required CD47, because CMs prepared from Cd47 -/mice were resistant to the effect of anti-CD47 blocking and Cd47 -/-CMs were more susceptible to phagocytic clearance at baseline ( Figure 2C) . These Figure 9B ). Furthermore, given that global Cd47 -/knockout mice have been reported to exhibit an increase in arterial diastolic and systolic pressure and that CD47 has also been shown to suppress nitric oxide (NO) signaling in vascular cells after long-term thombospondin binding (28), we assessed hemodynamics. However, no differences in systolic blood pressure were found after CD47 blockade (Supplemental Figure 9A ).
ACUTE CD47 BLOCKADE DURING REPERFUSION

AFTER MI ENHANCES MYOCARDIAL PHAGOCYTOSIS.
To specifically measure effects on myocardial phagocytosis, we used mice transgenic for Mhc6-mCherry, Figure 3A) , exhibited an increased profile of myocardial CD11b þ phagocytes with associated mCherry fluorescence ( Figure 3A and 3B) , an indicator of CM phagocytosis. Strikingly, mice administered adenoassociated virus CD47, which increased CD47 levels, exhibited reduced markers of myocardial phagocytosis ( Figure 3C) . Overexpression of CD47 did not affect infarct size, potentially owing to phagocytosisindependent signaling (Supplemental Figure 10) .
Importantly, anti-CD47 blocking strategies also led to other predicted consequences of enhanced clearance, namely, faster kinetics of cardiac innate immune cell resolution ( Figure 3D) , such as reduced Ly6cHI monocytes and heightened Ly6cLO monocytes cells (29) . Because no differences in neutrophil turnover were found, this suggested specificity for CM uptake.
Importantly, administration of antibodies did not affect initial levels or recruitment of blood-borne monocytes (Supplemental Figure 11) . Figure 5D ). Taken together, our data suggest a significant potential for incorporating CD47 blocking strategies toward the amelioration of cardiac injury. This approach is unique in its association and targeting of phagocytosis-associated repair.
DISCUSSION
Although cardiac reperfusion therapies have reduced patient mortality after AMI, improved survival has also led to increases in the frequency of heart failure.
A contributing factor to both the benefit and detriment of cardiac repair after ischemia and reperfusion is the Figure 4 ). In the models and examine conservation and reproducibility across species. Also, a closer look at our echocardiography data reveals that the slope of the reduction in the ejection fraction in the anti-CD47 cohort was greater than that in the control group ( Figure 5) . Therefore, additional studies should test the chronic benefit versus the transient nature of this treatment. It is important to consider phagocytosis-independent effects of CD47 blockade. For instance, CD47 targeting during tissue ischemia and reperfusion injury is associated with angiogenesis (42) and efferocytosis in heart can trigger vascular endothelial growth factor A (43).
However, we did not detect significant increases in vascular density (Supplemental Figure 9 ). CD47 also has an inhibitory effect on NO signaling. Hypoxia can induce NO synthases and increased NO signaling can improve cell survival under ischemia, in Cd47-null mice. In endothelial cells, NO production induces stimulation of vascular smooth muscle cells to promote vascular relaxation; however, induced CD47 ligand thrombosponidin-1 inhibits NO production and stimulates production of reactive oxygen species (44) .
In our own hands, CD47 blockade does not affect CM viability in vitro. Also, the effects on blood pressure were not found during CD47 blockade (Supplemental Figure 9 ). Finally, excessive phagocytic uptake has been shown to be detrimental in the central nervous system through phagocytosis-induced cell death (45) .
In this context, CD47 may in some instances act as a prophagocytic signal (46) . 
CONCLUSIONS
